Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Portal hypertension. Evidence-based guide].

Miguel Angel Mercado1, Héctor Orozco Zepeda, Juan José Plata-Muñoz

  • 1Clínica de Hipertensión Portal, Departamento de Cirugía, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México, DF.

Revista De Gastroenterologia De Mexico
|March 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of the repair of bile duct injury in a high-volume center in Latin America.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2025
Same author

BILE DUCT INJURY REPAIR IN A PATIENT WITH SITUS INVERSUS TOTALIS.

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery·2024
Same author

Perfusion Decellularization of Extrahepatic Bile Duct Allows Tissue-Engineered Scaffold Generation by Preserving Matrix Architecture and Cytocompatibility.

Materials (Basel, Switzerland)·2021
Same author

Subtotal Cholecystectomy After Failed Critical View of Safety Is an Effective and Safe Bail Out Strategy.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract·2021
Same author

Establishing consensus on the perioperative management of cholecystectomy in public hospitals: a Delphi study with an expert panel in Mexico.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2020
Same author

Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice?

Annals of surgery·2020
Same journal

[Severe bowel complications in SARS-CoV-2 patients receiving protocolized care].

Revista de gastroenterologia de Mexico·2024
Same journal

[Liver injury due to COVID-19 in critically ill adult patients. A retrospective study].

Revista de gastroenterologia de Mexico·2023
Same journal

[Reactive ileal lymphoid hyperplasia related to SARS-CoV-2 infection as a unique clinical feature resembling Crohn's disease].

Revista de gastroenterologia de Mexico·2022
Same journal

[Intestinal pseudo-obstruction: A rare presentation of congenital hypothyroidism].

Revista de gastroenterologia de Mexico·2022
Same journal

[Impact on the incidence of gastrointestinal perforation during the COVID-19 pandemic in the <i>Costa del Sol</i> healthcare system area].

Revista de gastroenterologia de Mexico·2022
Same journal

[Two consecutive attacks of diarrhea in 15 COVID-19 patients: An antibiotic-associated one following the viral one].

Revista de gastroenterologia de Mexico·2021
See all related articles

Treatment for portal hypertension has advanced, offering tailored strategies for primary prophylaxis, acute bleeding, and secondary prophylaxis. Pharmacotherapy and endoscopic therapies are key, with TIPS and surgery as options for specific patient groups.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Internal Medicine

Context:

  • Portal hypertension management has significantly evolved over recent decades.
  • Advances in understanding pathophysiology improve therapeutic applications and natural history prediction of varices and variceal bleeding.
  • Patient-specific treatment strategies are now possible based on liver function and underlying liver disease.

Purpose:

  • To outline current therapeutic options for portal hypertension based on clinical scenarios.
  • To detail the roles of pharmacotherapy, endoscopic interventions, TIPS, surgery, and liver transplantation.
  • To provide a framework for managing primary prophylaxis, acute bleeding episodes, and secondary prophylaxis of variceal bleeding.

Summary:

  • Primary prophylaxis favors pharmacotherapy, with endoscopic banding emerging as a future option.

Related Experiment Videos

  • Acute bleeding episodes are best managed with endoscopic therapy (sclerosis/banding) and/or pharmacologic agents (octreotide, terlipressin), with TIPS as a rescue intervention.
  • Secondary prophylaxis utilizes pharmacotherapy and endoscopic therapy as first-line treatments, followed by TIPS or surgery. TIPS is primarily for liver transplant candidates, while surgery benefits low-risk patients with preserved liver function. Liver transplantation addresses both portal hypertension and underlying liver disease in patients with poor liver function.

    • Impact:

    • Improved patient outcomes through evidence-based, individualized treatment algorithms for portal hypertension.
    • Enhanced prediction of bleeding risk allows for timely and appropriate preventative strategies.
    • Optimized utilization of diverse therapeutic modalities, including pharmacotherapy, endoscopy, TIPS, surgery, and transplantation, tailored to patient profiles.